C4X Discovery

We have a highly valuable and differentiated approach to Drug Discovery through our enhanced candidate molecule design and patient stratification capabilities, generating small molecule drug candidates focused on immuno-inflammation.

Nick Ray
CSO 
Emma Thomas
Business & Corporate Development Manager